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La chimie verte est une discipline relativement récente régie par douze principes fondateurs, 
incluant notamment l’économie d’atomes, la prévention de la pollution via des méthodes de synthèse 
chimique respectueuses de l’environnement, comme par exemple celles privilégiant le milieu aqueux 
aux solvants organiques, mais aussi le développement de produits chimiques et matériaux issus de la 
biomasse végétale. Dans ce contexte, la synthèse microbienne est un outil de choix pour supplanter, 
dans certains cas notables, les approches classiques basés sur la chimie organique de synthèse. Par 
exemple, les polyhydroxyalcanoates, des polyesters biodégradables, sont produits par voie 
bactérienne à partir de lipides et sucres et ils ont été identifiés comme des remplaçants potentiels au 
polypropylène dès les années ’70. 
Plus récemment, on commence à s’intéresser à la synthèse microbienne de composés sucrés 
polymériques, comme le dextrane ou la cellulose, ou lipidiques, comme les glycolipides amphiphiles. 
Bien que les pratiques de production microbienne de composés glycosylés datent de plusieurs 
décennies, l’essor de la chimie verte en tant que discipline au niveau international encourage des 
équipes de chercheurs pluridisciplinaires à se pencher sur la production, la diversification, l’étude des 
propriétés et les applications de cette classe de composés, dépassant ainsi la communauté des 
chercheurs en microbiologie, historiquement intéressés au développement des produits  de 
fermentation de microorganismes.  
Dans cet article nous souhaitons développer le thème mentionné ci-dessus en se focalisant sur 
la nanocellulose bactérienne, pour ce qui concerne les polymères glycosylés, et les biotensioactifs, 
pour ce qui concerne les systèmes lipidiques glycosylés. Le choix de ces deux systèmes est justifié par 
le fort développement des matériaux à base de nanocellulose mais aussi par le besoin de remplacer 
en partie les tensioactifs « classiques », sources non négligeable d’émission de CO2 au niveau mondial. 
Nous illustrerons les principales classes de molécules, les méthodes classiques de synthèse, les 
propriétés ainsi que quelques exemples d’application notoire. Nous terminerons par quelques 
perspectives sur le sujet.  
 
Abstract anglais 
Green chemistry is a recent discipline ruled by twelve founding principles, which include, 
among others, atom economy, the prevention of pollution via environmentally friendly chemical 
synthesis methods, such as, for example, the choice of an aqueous medium over organic solvents, but 
also the development of chemicals and materials derived from plant biomass. In this context, microbial 
synthesis is a tool to supplant, in some notable cases, syntheses by a standard organic chemistry 
approach. For example, polyhydroxyalkanoates, biodegradable polyesters produced by bacteria from 
lipids and sugars, were identified as potential substituents of polypropylene since the 1970s. 
More recently, attention has begun to be given to the microbial synthesis of polymeric sugars, 
such as dextran or cellulose, or lipids, such as amphiphilic glycolipids. Although the microbial 
production of glycosylated compounds can be traced back by several decades, the development of 
green chemistry as an international discipline is encouraging teams of multidisciplinary researchers to 
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focus on production, diversification, and applications of this class of compounds, thus going beyond 
the community of researchers in microbiology, historically interested in the development of 
fermentation products from microorganisms. 
In this article, we wish to develop the above mentioned theme by focusing on nanocellulose, 
representing an important glycosylated polymer, and on biosurfactants, in regards of the glycosylated 
lipids. The choice of these two systems is justified by the strong development of nanocellulose-based 
materials but also by the need to replace in part the "conventional" surfactants, a significant source of 
CO2 emissions worldwide. We will illustrate the main classes of molecules, the classical methods of 
synthesis, the properties as well as some examples of notorious application. We shall end with a few 
perspectives on the subject. 
 
Introduction 
The present work has the goal of illustrating two notorious examples of a sustainable chemistry 
approach in the field of molecular and material science. For the former, we have chosen the field of 
glycolipids, while for the latter, we have chosen the field of nanocellulosic materials. Glycolipids are 
generally considered as standard “green” surfactants in their alkyl polyglycoside (APG) form, obtained 
by standard glycosylation reactions from sugars and fatty oils.1 These products are commercially 
available in many detergent formulations. On the other side, nanocellulose has now became a 
standard “green” material derived from cellulose after a strong acid hydrolysis. To overcome these 
standard approaches, microbial fermemtation techniques have been developed since decades to 
prepare biobased glycolipids and nanocellulose. An overview of each domain, including standard 
synthesis, properties and up-to-date applications are presented below. 
 
Bacterial nanocellulose 
Nanocellulose: an introduction. Nanocellulose as a term originated only in the first decade of 
the 2000s2 but many of the current nanocellulose species had been in existence at a much earlier date.3 
At present, one of the most researched aspects of nanocellulose concentrates on their use as a 
reinforcing phase in bio-based and/or biodegradable composites that may step in to replace plastics 
or appear as completely new materials in their own right.4 In essence, nanocellulose is generally 
categorized under three discrete groups: cellulose nanocrystals (CNCs), cellulose nanofibers (CNFs) and 
bacterial cellulose (BC).2 CNCs and CNFs are usually extracted from plant sources and the basis of their 
production involves disintegration of the plant cell wall. CNFs are in fact isolated cellulose microfibrils, 
the basic supramolecular units of native cellulose. Microfibrils are longitudinal threads of very high 
aspect ratio, just a few nanometers in width yet micrometers in length.5 CNCs, in turn, are usually 
prepared by acid hydrolysis of native microfibrils. Controlled hydrolysis is able to degrade the 
disordered segments in the semi-crystalline cellulose microfibrils, leaving the crystallites intact.6,7 The 
end result is CNCs: short, rigid rods of crystalline cellulose that spontaneously self-assemble into chiral 
nematic liquid crystals beyond a certain threshold concentration. In this short review, however, we will 
focus only on BC. 
Bacterial cellulose: origin, preparation, morphology, general issues. BC is the odd one out of 
the nanocellulose family. It is usually treated as a separate category but essentially, BC could be 
considered a type of CNFs. BC consists of cellulose microfibrils synthesized by certain bacteria to an 
extracellular matrix.8 BC microfibrils are in a completely isotropic arrangement, lacking the tight 
hierarchical morphology of plant cellulose confined in the cell wall (Figure 1a). Therefore, one can say 
that BC is directly synthesized as a nanocellulose species without the need for specific isolation from a 
growth matrix. BC is also the only chemically pure form of nanocellulose as the other species are always 
embedded in a matrix of hemicellulose and – with land plants – lignin which are next to impossible to 
remove completely during nanocellulose preparation.9 It is only certain types of bacteria that are able 
to synthesize BC from glucose. The most popular species for actual BC production is called Acetobacter 
xylinum or in modern nomenclature, Gluconacetobacter xylinus. The BC synthesis was first reported in 
1886,10 although the product was only much later identified as cellulose.11 Culturing with G. xylinus is 
an aerobic process where BC grows at air/water surface in order to utilize the oxygen from air.8,12  The 
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most used monosaccharide sources for BC production are glucose and sucrose. Glucose is converted 
via several steps into uridine diphosphoglucose (UDP-glucose) which is then polymerized into cellulose, 
i.e., a homopolymer consisting only of anhydroglucose units (Figure 1d).8,12 BC producing microbes are 
also able to utilize other monosaccharides to produce UDP-glucose and further to cellulose. A case in 
point is fructose – the other monosaccharide in the sucrose dimer – but several other monosaccharides 
have been trialed as a cellulose source as well.8 Commonly, the method of growing BC in static 
conditions at the air/water surface is relatively slow but nevertheless suitable for laboratory work. A 
few semi-continuous bioreactor designs for static culturing have been proposed throughout the past 
years.13 Moreover, submerged fermentation has been investigated but the techniques face intrinsic 
problems, above all the supply of oxygen is usually too low for sufficient production.14 BC consists 
chemically from exactly the same polysaccharide that makes up the cellulose microfibrils in plant cell 
walls. BC strands are also called microfibrils but their morphology is somewhat different to those in 
plants. Cellulose microfibrils in plants are monodisperse in width, generally 3-20 nm depending on the 
botanical source, and micrometers in length, that is, they are somewhat reminiscent of spaghetti in 
nanosized form. Instead of a more or less square cross sectional shape prevalent in plants, BC 
microfibrils possess a rectangular cross section with sides of 7 × 70-145 nm, thus rendering the 
appearance of the microfibrils in the shape of flat ribbons, somewhat reminiscent to tagliatelle in 
nanosized form. Fink et al. proposed that the flat microfibrils consist of elementary fibrils of 7 × 13 nm 
cross section. Indeed, when preparing CNCs from BC, the flat structure is broken also at the crystallite 
level and the cross sections of the CNCs bear roughly the dimensions of 7 × 7 nm. 
 
 
Figure 1 – a) Scanning electron micrograph of bacterial cellulose gel. The gel still contains the bacteria which are generally 
removed after culturing by a simple washing step. Reproduced from ref. 8. Copyright Springer 2000; b) Average tensile 
properties of BC in comparison to some commonly used synthetic and renewable fibers. c) Tensile strength versus tensile 
modulus of selected BC composites. The dashed lines denote tensile properties of neat PLA. Reproduced from ref. 15. 
Copyright Elsevier 2014. d) Simplified pathway from glucose to bacterial cellulose 
 
Applications of bacterial cellulose. The peculiar feature of BC is that it forms a hydrogel pellicle 
after the synthesis. The pellicle consists of isotropic BC microfibrils. Additionally, BC is exceptionally 
effortless to purify from other components that cellulose; a mild alkali washing is sufficient to remove 
the bacteria and additional sugars. In other words, BC is a nanocellulose hydrogel in a very pure form, 
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which is something that many nanocellulose procedures are attempting to achieve from plant 
materials with much effort. It is, therefore, quite an obvious development that BC has been subjected 
to similar investigations as the rest of the nanocellulose family, composite materials being among the 
most popular targets for applications. Furthermore, biomedical applications, particularly wound 
dressing materials, have been fashionable with BC because of its chemical purity and non-toxicity. The 
rationale for using BC as a reinforcing phase in composites stems from its exceptionally high 
mechanical strength. Figure 1b shows the tensile strength and modulus of BC nanofibers in the context 
of a variety of other natural and synthetic fibers.15 In general, the values reported for individual BC 
nanofibers as well as other nanocellulosic species vary somewhat, depending on the measurement 
technique.15 It is obvious that BC works well as a composite reinforce: Figure 1c shows a collection of 
data from BC/polymer composites where the tensile strength has been plotted as a function of 
modulus.15 The dashed lines denote the strength and modulus of poly(lactic acid) (PLA) because of its 
status as one of the highest performing non-petroleum derived polymers. The performance of BC and 
other nanocellulose grades has not lived up to their theoretical potential in polymer composite 
materials.15 One of the major problems is the incompatibility between cellulose and the continuous 
composite matrix. Polymer matrices are often hydrophobic, resulting in aggregation and phase 
separation of the cellulose when mixed together.16 Another seminal challenge is the susceptibility of 
BC to water and humidity: as with ordinary paper products, the strength of nanocellulose-containing 
products is usually impaired when in contact with water or vapor.17 Multiple ways of surface modifying 
all kinds of nanocellulosic grades for better compatibility or water resistance exist18 but the methods 
are usually not suited for large scale production required for composite preparation. For 
comprehensive reviews on polymer/nanocellulose composites, the reader is referred to articles by Siró 
and Plackett,19 Siqueira et al.20 and Lee et al.15 
Biomedical applications are another strong research trend with BC-containing materials. Wound 
dressing, in particular, has received a lot of attention with even commercial or pre-commercial 
products in the line.21 Here, the high mechanical strength of BC, its hygroscopicity, non-toxicity, 
antimicrobial nature, and ability to geometrically conform in various shapes are seen as the principal 
assets. The similarity of BC nanofibers with collagen fibers of the skin improves the biocompatibility. 
Other biomedical applications of BC include tissue-engineering22 and drug delivery.23 
 
Microbial glycolipid biosurfactants 
The surfactant market. Surfactants are performance molecules that intervene in nearly every 
product and aspect of human daily life and find applications in/as very broad array of markets and 
applications: chemical, pharmaceutical, cosmetic & personal care, packaging, carpets & textiles, 
detergents, paper, adhesives, (3D printing) inks, mining and leaching, healthcare, polymer, food and 
feed, paints, surface and industrial coating, etc. The global turnover of surfactants was worth USD 
30.64 Billion in 2016 and is expected to reach USD 39.86 Billion by 2021, registering a CAGR of 5.4% 
between 2016 and 202124 which shows that they are bulk products with a significant economic and 
environmental impact. Despite the efforts to move towards a more environmental friendly economy, 
only 3 % of the surfactant market share consists out of molecules, which are 100 % biobased and even 
a smaller part < 0,5 % of entirely biologically produced biobased surfactants, such as microbial, plant 
based or enzymatically produced biosurfactants. There are myriad pathways to process crude oil or 
gas towards the hydrophobic building blocks of synthetic surfactants, e.g. Fischer-Tropsch synthesis, 
oxo process, olefin oligomerization or Friedel-Crafts alkylation. The constant consumer and hence 
market demand for sustainable, biobased and green solutions, has resulted in a substantial increase 
of the development and use of partly biobased and even wholly biobased surfactants (WBS) (100 % 
derived from renewable (non-fossil) biomass in such applications.25 With respect to this terminology: 
the European Commission has issued a mandate to the European Commission, for Standardization 
(CEN) to generate general standards providing a common basis with respect to terminology, bio based 
content determination, sustainability aspects, life cycle analysis and declaration tools for Business to 
Business (B2B) and Business to Consumer (B2C), which was done within the CEN/TC-276 technical 
committee in cooperation with the ERASM Biosurfactant Taskforce (www.erasm.org). Shortly said, the 
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four categories are shown in Figure 2a and range from > 95 % (wholly bio-based); > 50 % and < 95 % 
(majority bio-based); > 5 % and < 50 % (minority bio-based) and < 5% (non bio-based). The wholly bio-
based surfactants (WBS) according to ISO 16128 norm, represent about 3 % of the European surfactant 
market and have the best image. Subsequently, there is a strong drive of the industry to apply this type 
of surfactants in their products, of course without giving in performance or cost. Most WBS are based 
on sugars coupled to fatty acids and/or alcohols i.e. methylester sulphonates, alkylpolyglucosides, 
sorbitan esters, anionic APG derivatives, sucrose esters, methyl glucoside esters, fatty acid N-
methylglucamides, alkylpolypentosides, etc. However, some limitations/drawbacks are associated 
with the current WBS portfolio:  
- the largest part of the wholly biobased surfactants on the market are produced through chemical 
processes, which negatively impacts their environmental profile  
- functionality/variety is limited 
- they do not offer an easy possibility for further derivatization/functionalization 
- they show good performance, but do not boost performance by e.g. combining properties justifying 
their higher price 
- can only be produced from first generation substrates 
Several new technologies are currently being developed, that can alleviate these issues. Related to the 
first hurdle, full biological production processes are associated with an even better environmental 
profile and additionally offer better marketing opportunities to the companies, which is a big driver. 
 
 
Figure 2 – a) Use of bio-based and non bio-based surfactants in the European Union, Norway, Switzerland and Iceland 
(2015).25 b) Glycolipid portfolio developed by InBio.be based upon the yeast Starmerella bombicola. c) Representation of 




Biosurfactants. The current state of the art for biologically produced surfactants (estimated by 
the authors to currently only account to a few thousand tonnes per annum thus representing only a 
very small amount of the surfactant market share) can be defined as: 
- plant derived molecules like e.g. saponins or cardolite commercialized by e.g. Foodchem, Dr. H. 
Schmittmann GmbH and Cardolite respectively 
- enzymatically produced molecules like e.g. enzymatic sugar esters, which are not on the market yet, 
but a lot of research is conducted in this field 
- microbially produced molecules like sophorolipids (SLs) launched on the B2B market by Soliance, 
Evonik and planned by Croda and applied by Ecover, Saraya, Henkel, Soliance, etc.; rhamnolipids (RLs) 
commercialized by Logos, Jeneil, Urumqi Unite Biotechnology, Biotensidon, Agae and Rhamnolipid.inc; 
Mannosylerythritol lipids (MELs) commercialized by Toyobo, Kanebo, Damy Chemicals, Biotopia co. 
and investigated by many more; Lipopeptides (LPs) commercialized by Lipofabrik, Kanebo and Kaneka 
and Xylolipids (XLs) to be commercialized by INS. 
Microbial surfactants already offer a solution to the first drawback mentioned above. They have been 
very extensively investigated as they offer some opportunities, e.g they can be produced from second 
generation (2G) substrates and waste streams like molasses, animal fats, dairy industry whey and other 
waste or side streams26,27. Recently, efficient sophorolipid production (wild type) was shown on 100 % 
2G substrates (both hydrophilic as hydrophobic part) inside the framework of the BBI Carbosurf 
project, which will be published elsewhere. Derivatization efforts for sophorolipids -the best 
represented microbial biosurfactant on the market- have been investigated quite extensively28. In 
terms of chemical derivatization of wild type SLs, too many hurdles, like low yield and low uniformity 
related to the original complexity of the wild type SLs, are associated with these processes. Enzymatic 
derivatization strategies have also been investigated28 and even commercialization efforts were done 
by the American company Synthezyme. 
Three main reasons can be defined to explain low commercialization levels of biosurfactants. 
Cost considerations are to date the prime hindrance to market penetration of (microbial) 
biosurfactants. The maturity of the petrochemical industry makes purely cost-based competition 
unrealistic for most biosurfactants. Moreover, even the availability of biosurfactants with equivalent 
performance and at the same cost would not per se be sufficient to drive acceptance and utilization 
by consumers and brand owners. A better performance at an acceptable premium price would 
increase their marketability for mass consumption products as consumers anno 2017 demand 
environmentally friendly and benign products/processes, without wanting to give away 
functionality/performance. This situation requires the development of innovative and new solutions 
as the industry is currently increasingly driven by consumer awareness and opinion. A second hurdle 
is the lack of diversity. Formulation experts are like artists, demanding a diversified palette of 
molecules to shake and stir to get to a desired endpoint. Whereas the chemical industry has been very 
successful in developing an extraordinary wide variety of surfactant structures for a multitude of 
applications/functions, the biobased counterparts have not been able to offer the same diversity. To 
give an example, the chemically produced biosurfactants APG’s (alkyl polyglucosides), mainly consist 
of mono-glucosylated (degree of polymerisation (DP) = 1) molecules and a small amount of di-
glucosylated (DP = 2) molecules. Consequently, the structural diversity of these biosurfactants is rather 
low with an average DP ranging between 1,2 and 1,6. Although APGs are one of the most prominent 
biosurfactants on the market, their narrow product spectrum limits further growth. Moreover, they 
do not offer a possibility for further derivatization/functionalization. Several new technologies are 
currently being developed. The large chemical company Evonik for example launched sophorolipids, a 
microbial biosurfactant, as an ingredient on the European B2B market in 2015, while they are currently 
taking actions to do the same for the microbial surfactant rhamnolipids. Also other big companies like 
Croda and Henkel are highly active in this field. Although these observations are already a step in the 
right direction, the biosurfactant diversity can still by far not compete with the portfolio of fossil 
derived surfactants. A third reason is the fact that (microbial) biosurfactants typically are defined by 
the occurrence of very similar congeners i.e. production of mixtures. For the microbial biosurfactants 
sophorolipids, these are mainly divided into a mixture of lactonic and acidic sophorolipids (Figure 2c). 
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Additional variation within the congeners in the hydrophobic tail length, saturation degree and 
positioning of the sophorose head group (terminal (ɷ) and subterminal (ɷ-1) (Figure 2c). Easily over 
30 congeners can as such be identified in ‘sophorolipids’, which are thus not defined by one single 
molecule. Mixtures might do the job and could thus be perfectly marketed, but these biological 
systems are sensitive to small variations in medium/cultures conditions, which will influence the 
composition of the mixture, which in turn gives rise to very different properties. This in-product-
variation is one of the reasons of the very varying reports in the literature on their properties. The 
latter is simply unacceptable from an industrial point of view. Combined with the reasons mentioned 
above, this is one of the main reasons why microbial biosurfactants currently only represent a marginal 
part of the surfactant market. 
A number of solutions can be defined for the mentioned bottlenecks. Variation can be 
increased by applying chemical and/or enzymatic derivatization possibly in combination with an 
expansion of the molecular variety through genetic engineering. The latter can also increase 
productivity (decrease of price) and uniformity (decrease of mixtures). The efforts spread over the past 
15 years,29 especially at the University of Ghent (Belgium),30,31,32 have resulted in the generation of a 
proprietary platform technology for the production of new types of glycolipid molecules (Figure 2b). 
This has been accomplished by the development of molecular techniques and constant expansion of 
the molecular toolbox for this non-conventional yeast and through the development and use of several 
-omic strategies. Although these engineering efforts have thus been quite successful, none of the 
abovementioned efforts have yet resulted in the commercialization of a new-to-nature compound. 
This is due to a few reasons:  
- new molecules translate/correspond with new processes, different properties and thus different 
applications.  
- the non-optimized production processes and strains logically correspond with higher production costs  
- the absence of the molecules on the market works inhibitory for the economy of scale to kick in nor 
is regulatory approval granted (or data available for initiation of a regulatory dossier) although the 
related wild type SLs are. 
- the lack of knowledge on the properties of these new molecules 
These hurdles are thus the next steps to take to valorized this technology and this is done by applying 
an integrative process design approach combining strain engineering with process development and 
optimization. 
Applications. The discussion above mainly concerns the surface active properties, by far the 
most important from an industrial development point of view, of microbial glycolipid biosurfactants. 
However, a series of new perspectives have been opened by research groups working mainly in Japan, 
India, France and USA. The biocompatibility of most glycolipids and the presence of the free carboxylic 
acid group made them interesting candidates for the water stabilization of metal and metal oxide 
nanoparticles. The first work in this field was proposed by the group of Prasad at the NCL in Pune, 
India. Cobalt,33 silver,34 gold35 but also iron oxide36 nanoparticles (Figure 3a) have been used as systems 
to be coated with the acidic form of sophorolipids. In all cases, the resulting sophorolipid-coated 
system is highly dispersible in water and it was shown that, in the case of metal systems, sophorolipids 
can also act as a reducing agent, thus excluding the use of strong, classical, reducing agents like NaBH4. 
Cytotoxicity and genotoxicity tests performed on the gold and silver nanoparticles systems have shown 
no specific biological activity below 100 g/mL,35 thus making these systems interesting candidates for 
biomedical applications. The impact of the sophorolipid coating on the colloidal stability was shown 
for the iron oxide nanoparticles, which were shown to be dispersible and stable in time up to 2 M KCl 
solution, thus showing the strong stability of the COOH-FeOx complex.36 Antimicrobial activity of 
glycolipid biosurfactants in solution is a field of research since a long time. However, more recent works 
have shown their interest as surface antimicrobial and/or antiadhesive coatings. Dispersion of 
rhamnolipids on both hydrophobic (octadecyltrichlorosilane-modified glass) and hydrophilic (hydroxyl-
rich glass) surfaces were shown to have an interesting antiadhesive effect on Gram-negative E. coli, P. 
putida and P. aeruginosa and on Gram-positive B. subtilis. In particular, adhesion of P. aeruginosa 
(number of attached cells per mm2) was reduced by a factor 15 on the hydrophilic and by a factor 20, 
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respectively, on the hydrophilic and hydrophobic glass substrates with respect to control.37 (Figure 3d) 
This system, together with B. subtilis, were by far the most effective with respect to the other 
pathogens tested in the study. On the contrary, if the glycolipid (sophorolipid) is chemically grafted on 
the substrate via its pending COOH group (amidation reaction with a surface aminothiol primer 
deposited on gold), biocidal properties against both Gram-positive (L. ivanovii, E. faecalis, S. 
epidermidis, S. pyogenes) and Gram-negative (E. coli, P. aeruginosa, S. typhymurium) bacteria are 
observed instead.38,39 If the efficiency is, in the best case, only of about 45% of the bacterial population 
present on the surface, these works show the first biocidal effect of a glucose derivative and join the 
debate concerning the interactions between carbohydrates and cell membranes.40,41  
  
 
Figure 3 – a) Sophorolipid-capped silver nanoparticles (morphology, size, structure and organic content are respectively 
presented in panels A-B, C and D). Reproduced from ref. 42. Copyright Royal Society of Chemistry 2008. b) Self-assembled 
nanoscale twisted ribbons obtained from stearic acid sophorolipids. Reproduced from ref. 43. Copyright Wiley-VCH Verlag 
2015. c) Glucosomes obtained from branched C22 sophorolipids. Reproduced from ref. 44. Copyright Wiley-VCH Verlag 2017. 
d) Antiadhesive effects of rhamnolipids-coated glass substrate. Reproduced from ref. 37. Copyright Wiley-VCH Verlag 2013 
 
Surfactants are known to spontaneously self-assemble in water, and glycolipid biosurfactants 
do not derogate this rule. Self-assembly properties have been reported for mannosylerythritol lipids, 
rhamnolipids, sophorolipids, glucolipids, cellobioselipids, just to cite the most important ones.45–50 If 
9 
 
the knowledge in this field is more or less advanced according to the effort that a specific research 
group has dedicated to a given family of molecules, one can summarize, without being exhaustive, the 
following morphologies: micelles,45,50–52 vesicles,45,48,49 fibers,48,49 lamellar,45,48 sponge45 phases (Figure 
3b-c). The nature of the molecule and concentration are the most obvious parameters that influence 
the self-assembled morphology, but pH47,51,53 and temperature45,47 have also been shown to have a 
strong influence on the self-assembly properties. This impressive load of work is still ongoing because 
the relationship between the structure of a given microbial glycolipid and the corresponding self-
assembled phase is not obvious and cannot be based on the classical prediction based on packing 
parameter considerations, as recently shown for acidic oleic acid sophorolipids, which can form 
micelles or giant ribbons as a function of the purity but also, for a 100% pure compound, as a function 
of the preparation method.54 One must here observe that microbial glycolipid systems are in fact never 
pure and in fact very hard to fully purify, because it is well known that microbial synthesis provide a 
system with a wide range of structurally-similar congeners where one or two are majoritarian. 
 Gene transfection, which consists in the delivery of genetic material across the cell membrane, 
is one of the applications in which control of self-assembly, and colloidal properties in general, is very 
important. In this field, mannosylerythritol lipids (MEL) have been employed as adjuvants in gene 
transfection of plasmid DNA using cationic liposomes as classical carriers and DNA binders.45 It was 
shown that the presence of MEL increases the efficiency of gene transfection in NIH3, COS-7 and HeLa 
cells up to 50 to 70 times. The role of MEL seems to be the acceleration of membrane fusion between 
the cationic liposome and cell membrane, so that transfection efficiency is increased. More recently, 
quaternary ammonium-modified sophorolipids have been incorporated into negatively-charged DOPE 
liposomes and used as direct binders of negatively-charged plasmid DNA, to be transfected into A549, 
16HBE and SKMEL28 cell lines.55 Authors have found that two specific, long-chain, quaternary 
ammonium derivatives were highly efficient and with low cytotoxicity. The main difference between 
this work and the approach using MEL is the positively-charged sophorolipid obtained by chemical 
modification and its direct binding to plasmid DNA, thus giving it a direct role in terms of vectorization.  
 
Conclusion 
The present contribution shows two families of carbohydrate-rich compounds of microbial 
origin, one polymeric and the other molecular. Bacterial cellulose is an interesting polysaccharide 
challenging the use of plant cellulose for the easier approach in the purification and good water-
dispersion properties. On the other side, microbial glycolipids are versatile compounds both in terms 
of lipid and carbohydrate structure that can self-assemble into a wide range of morphologies (micelles, 
vesicles, fibers…) and be used as antimicrobial and surface stabilizing agents, among others. Both 
families of compounds are biodegradable and non-toxic and have the goal of substituting, in the long 
run, petrochemical compounds. Nonetheless, in both cases, the industrial development of a fully 
microbial-based organic chemistry is far from being a present reality due to the high production costs 
and product variability.   
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